Lack of effect of proteinase-activated receptor 2 (PAR2) deletion on the pathophysiological changes produced by lipopolysaccharide in the mouse:comparison with dexamethasone

H. Kazerani, R.J. Plevin, J. Kawagoe, T. Kanke, B.L. Furman

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Four pentacyclic tritepenes were isolated from Combretum imberbe Engl. & Diels, of which two are novel glycosidic derivatives of 1α,3β,23-trihydroxyolean-12-en-29-oic acid (hydroxyimberbic acid). Terminalia stuhlmannii Engl. & Diels stem bark yielded two glycosides of hydroxyimberbic acid, one of which is reported for the first time. The structures of the isolated compounds were elucidated by spectroscopic methods. Several of the compounds had antibacterial activity, imberbic acid showing particularly potent activity against Mycobacterium fortuitum and Staphylococcus aureus.
Original languageEnglish
Pages (from-to)1015-20
Number of pages6
JournalJournal of Pharmacy and Pharmacology
Volume56
Issue number8
DOIs
Publication statusPublished - 2004

Keywords

  • proteinase-activated receptor-2
  • lipopolysaccharide
  • dexamethasone

Fingerprint Dive into the research topics of 'Lack of effect of proteinase-activated receptor 2 (PAR2) deletion on the pathophysiological changes produced by lipopolysaccharide in the mouse:comparison with dexamethasone'. Together they form a unique fingerprint.

  • Cite this